Sidroga Gastrointestinal Verdauungstee 20 Btl 1.5 g

Herbal medicinal product

AMZV

What is Sidroga Gastrointestinal Digestive Tea and when is it used?

Sidroga Gastrointestinal Digestive Tea contains the following dried, cut plant parts: sweet flag root, chamomile flowers, yarrow herb, centaury and lemon balm leaves. Traditionally, these are used to treat digestive problems such as a feeling of fullness, belching and flatulence and to stimulate your appetite.

What should you be aware of?

If your symptoms worsen or do not improve after 14 days, you should consult a doctor.

In the case of persistent or recurring digestive disorders, a doctor must be consulted.

When can Sidroga be used Gastrointestinal Digestive Tea should not be used or only with caution?

Sidroga Gastrointestinal Digestive Tea must not be used

• if there is a known hypersensitivity to one of the active ingredients or one of the ingredients (see "What does Sidroga Gastrointestinal Digestive Tea contain?") or against other plants from the daisy family.
• if you suffer from stomach and intestinal ulcers.

There are insufficient studies on the use and safety of Sidroga Gastrointestinal Digestive Tea in children. Therefore, taking this medicine is not recommended for children under the age of 12.

Inform your doctor, pharmacist or druggist or your doctor, pharmacist or druggist if you

• suffer from other diseases,
• have allergies or
• take other medicines (including those you bought yourself!).

Can Sidroga Gastrointestinal Digestive Tea be used during pregnancy or while breastfeeding time to be taken?

Based on previous experience, there is no known risk for the child when used as intended. However, systematic scientific investigations have never been carried out. As a precaution, you should avoid taking medicines during pregnancy and breastfeeding, or ask your doctor, pharmacist or druggist for advice.

How do you use Sidroga Gastrointestinal Digestive Tea?

Adults and adolescents from the age of 12 drink 1 cup of tea 3 times a day, ½ hour before meals.

Preparation: 1 filter bag Sidroga Gastrointestinal Digestive Tea is poured over about 150 ml of boiling water and left to infuse for 5 to 10 minutes. Then gently squeeze out the bag and take it out.

The use of Sidroga Gastrointestinal Digestive Tea in children under the age of 12 has not yet been tested.

The duration of use is not limited. Follow the dosage given in the package leaflet or prescribed by the doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.

What side effects can Sidroga Gastrointestinal Digestive Tea have?

The following side effects can occur when taking Sidroga Gastrointestinal Digestive Tea:

Headaches may occur in people sensitive to bitter substances. Allergic skin reactions have been reported.

It is not possible to specify the frequency of occurrence of side effects.

No cases of overdose have been reported.

If you notice any side effects that are not described here, you should inform your doctor, pharmacist or druggist.

What else needs to be considered?

Sidroga Gastrointestinal Digestive Tea is at room temperature (1st 5-25 °C) and out of the reach of children.

The double-chamber bags in aroma protection packaging may only be stored up to the end marked on the container with «Exp.» designated date.

Your doctor, pharmacist or druggist can provide you with further information.

What does Sidroga gastro-intestinal digestive tea contain?

1 double-chamber bag of 1.5 g contains the following dried and cut plant parts as active ingredients: 0.3 g calamus rhizome, 0.3 g chamomile flowers, 0.3 g yarrow herb, 0.3 g centaury and 0.225 g lemon balm leaves. Other ingredient: three-lobed sage.

Approval number

65137 (Swissmedic).

Where can you get Sidroga Gastrointestinal Digestive Tea? Which packs are available?

In pharmacies and drugstores, without a doctor's prescription.

Boxes with 20 double-chamber bags in aroma protection packaging.

Authorization holder

Sidroga AG, 4310 Rheinfelden.

This leaflet was last checked by the drug authority (Swissmedic) in August 2015..